Dasatinib is effective against optic nerve infiltration of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Satake
Atsushi
A
Okada
Masaya
M
Asada
Takako
T
Fujita
Kyoko
K
Ikegame
Kazuhiro
K
Tamaki
Hiroya
H
Fujimori
Yoshihiro
Y
Ogawa
Hiroyasu
H
D000368:Aged; D000069439:Dasatinib; D005260:Female; D006801:Humans; D017254:Leukemic Infiltration / Q000188:drug therapy* / Q000473:pathology; D009900:Optic Nerve / Q000473:pathology*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000473:pathology; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines / Q000627:therapeutic use*; D013844:Thiazoles / Q000627:therapeutic use*; D016896:Treatment Outcome; D014792:Visual Acuity / Q000187:drug effects
D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D013844:Thiazoles; D000069439:Dasatinib